Skip to main content

Here, kitty kitty

I am waiting for a hypoallergenic cat. Not one to keep, but just one to prove all the skeptics wrong. In the January issue of the The Scientist I wrote an linkurl:article;https://www.the-scientist.com/article/display/39383/ about what scientists think of Allerca's hypoallergenic cats. The California company claims to have found and bred the world's first scientifically proven hypoallergenic cat, but most of the scientists I spoke with are dubious of its claims, not to mention the founder has a bi

Written byKerry Grens
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
I am waiting for a hypoallergenic cat. Not one to keep, but just one to prove all the skeptics wrong. In the January issue of the The Scientist I wrote an linkurl:article;https://www.the-scientist.com/article/display/39383/ about what scientists think of Allerca's hypoallergenic cats. The California company claims to have found and bred the world's first scientifically proven hypoallergenic cat, but most of the scientists I spoke with are dubious of its claims, not to mention the founder has a bit of a criminal past and Allerca continues to find itself in linkurl:trouble.;https://www.bizben.com/blog/posts/223-california-franchises-make-list.php/ The company promised to deliver the first batch of kitties this spring--and with the equinox approaching I emailed the press office to catch up on Allerca's progress. It's been a day and no one has responded, and I have yet to find any news reports of these $4,000 cats making it to their new homes. Yet the company's linkurl:website;https://www.allerca.com/ states that 'Customers who now own GD cats report that they make great family pets and are wonderful with children.' A few other sections of the website caught my eye as I was checking for updates. For one, the nonsense linkurl:data;https://www.the-scientist.com/article/display/39381/ Allerca had posted--and which received criticism in my article--are no longer there, and the description of Allerca's screening technology has been modified. Also, though Allerca is only into the third generation of hypoallergenic cats, now just a few years old, the company claims they 'have a long life expectancy.' How do they know? It would be great to prove the skepticism of those in my article wrong. Cat allergies affect millions and many of those people would love to be pet owners; it's no surprise Time and Good Morning America praised Allerca for its work. Several months back I interviewed Allerca's founder Simon Brodie and he said the proof will be in the pets. So again I invite Allerca, as I did several months ago, to show us the proof.
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member?
Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • kerry grens

    Kerry served as The Scientist’s news director until 2021. Before joining The Scientist in 2013, she was a stringer for Reuters Health, the senior health and science reporter at WHYY in Philadelphia, and the health and science reporter at New Hampshire Public Radio. Kerry got her start in journalism as a AAAS Mass Media fellow at KUNC in Colorado. She has a master’s in biological sciences from Stanford University and a biology degree from Loyola University Chicago.

    View Full Profile
Related articles background image
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad
Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

Beyond the Basics: Strategies for Single-Cell and Spatial Transcriptomics Analysis

bioxcell
Scientist reviewing cellular and molecular data on a computer in a laboratory.

Building Translation-Ready Biomarkers with Connected Workflows

Danaher Logo

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays